Brasília – Nineteen healthcare and pharmaceutical industry associations issue a joint manifesto opposing the fast-track processing of Bill 4,741/2024, which proposes the creation of a single Health Technology Assessment (HTA) agency in Brazil. The proposal, authored by Congressman Dr. Luizinho, seeks to expand the role of the National Supplementary Health Agency (ANS) to centralize decisions on the incorporation, exclusion, and revision of health technologies across the system.

Stakeholders warn that the initiative may create regulatory overlaps, increase bureaucracy, and generate legal uncertainty by redistributing responsibilities currently held by established bodies such as the National Commission for Health Technology Incorporation (CONITEC). They also caution that merging HTA processes between the public and private sectors—currently structured differently—could affect access to innovation and disrupt the balance between sustainability and coverage, calling for broader technical debate before advancing the bill.

Source: Futuro da Saúde